The beneficial association of the Mediterranean diet (MedDiet) with longevity has been consistently demonstrated, but the associations of MedDiet components have not been accordingly evaluated. We performed an updated meta-analysis of prospective cohort studies published up to 31 December 2017, to quantify the association of adherence to MedDiet, expressed as an index/score (MDS) and of its components with all-cause mortality. We estimated summary relative risks (SRR) and 95 % CI using random effects models. On the basis of thirty studies (225 600 deaths), SRR for the study-specific highest/lowest and per 1SD MDS increment were 0·79 (95 % CI 0·77, 0·81, Ι 2 = 42 %, P-heterogeneity 0·02) and 0·92 (95 % CI 0·90, 0·94, Ι 2 56 %, P-heterogeneity <0·01), respectively. Inversely, statistically significant associations were evident in stratified analyses by country, MDS range and publication year, with some evidence for heterogeneity across countries overall (Pheterogeneity 0·011), as well as across European countries (P = 0·018). Regarding MDS components, relatively stronger and statistically significant inverse associations were highlighted for moderate/none-excessive alcohol consumption (0·86, 95 % CI 0·77, 0·97) and for above/ below-the-median consumptions of fruit (0·88, 95 % CI 0·83, 0·94) and vegetables (0·94, 95 % CI 0·89, 0·98), whereas a positive association was apparent for above/below-the-median intake of meat (1·07, 95 % CI 1·01, 1·13). Our meta-analyses confirm the inverse association of MedDiet with mortality and highlight the dietary components that influence mostly this association. Our results are important for better understanding the role of MedDiet in health and proposing dietary changes to effectively increase adherence to this healthy dietary pattern.
the heterogeneity across studies and (3) to evaluate the relative contribution of the individual components of this diet in the overall association of the MedDiet with mortality.
Methods

Search strategy
As a starting set, we used those studies published up to June 2013, which were included in the latest meta-analysis by Sofi et al. (4) . Furthermore, in December 2017, we carried out a literature search in the PubMed database using the following keywords: ( . Studies were included if they (i) had a cohort design or were case-control studies nested within cohorts, (ii) used a MedDiet index/score (labelled as MDS hereafter) defined a priori, (iii) investigated allcause mortality and examined associations with MDS and (iv) provided the RR estimate (i.e. risk or rate ratios (RRa) hazard ratios (HR) or OR) and the corresponding 95 % CI, or sufficient information for their calculation. In all, three authors (C. B., D. E. and V. B.) independently screened the search results against these criteria to identify eligible articles, and checked the reference list of the publications retrieved to identify additional publications. Discrepancies were discussed and resolved in consensus. If additional data were requested from the identified publications, contact with authors was realised.
Study selection
The flow chart for the selection procedure, undertaken by our group in December 2017, is shown in Fig. 1 . The corresponding 264 articles were selected by PubMed 236 were excluded because:
(a) they examined a different outcome and/or exposure, (b) there were reviews or discussions on the possible effects of MD on health or other related issues, (c) the association of MD with various endpoints including all-cause mortality was assessed among specific populations (e.g. people with CVD,diabetes mellitus, cancer, etc.)
Twenty-eight articles potentially eligible
Twelve studies excluded:
one systematic review and meta-analysis did not provide the respective HR for the included cohort studies; three studies used a posteriori factor analyses to derive the so-called MD patterns; one study was a discussion of previously reported findings; one study examined changes in MD scores from baseline to follow-up with subsequent mortality; one study did not report the HR for the association of MD with total mortality; one study referred to a discussion on findings of the PREDIMED randomised control trial; one study examined MD as a potential factor for recommendation among primary care physicians; one study examined MD as modifier of the effect of multivitamin use on total mortality; two studies analysed the same cohorts as more informative studies that were included in the current meta-analyses
Sixteen articles remained
Meta-analysis of MD: sixteen studies Meta-analysis of MD components: seven studies Fig. 1 . Selection strategy to identify studies that were published from 1 July 2013 to 31 December 2017 and were included in the meta-analysis of the Mediterranean diet (MD) and overall mortality. HR, hazard ratio; PREDIMED, PREvención con DIeta MEDiterránea.
information for studies published up to June 2013 has been published (4) . This search identified 264 articles, with all abstracts published in English, included in the PubMed database, which were fully examined. From these, 236 were excluded because (a) they examined a different outcome and/ or exposure, (b) there were reviews or discussions on the possible effects of the MedDiet on health or other related issues and (c) the association of the MedDiet with various end points including all-cause mortality was assessed among specific populations (e.g. people with CVD, diabetes mellitus, cancer and so on). From the remaining twenty-eight papers, the following were further excluded: one systematic review and metaanalysis evaluating the health effects of the MedDiet with various health outcomes (11) because it did not provide the respective HR for the included cohort studies; three studies (12) (13) (14) because the so-called MedDiet patterns were derived from a posteriori factor analyses and not a priori; one study (15) because it was a discussion of previously reported findings that are included in the current meta-analysis (16) ; one study (17) because the association with all-cause mortality was examined for changes in MedDiet scores from baseline to follow-up, and therefore could not match the rest of the studies that reported associations of baseline MedDiet with subsequent mortality; one study because it did not report the HR for the association of the MedDiet with total mortality but only for CVD incidence/ mortality (18) ; the study of Guasch-Ferré et al. (19) because it referred to a discussion on findings of the PREvención con DIeta MEDiterránea (PREDIMED) RCT; the study by Ebell & Grad (20) in which the MedDiet was examined as a potential factor for recommendation among primary care physicians; and the study by Rautiainen et al. (21) in which the MedDiet was examined as a modifier of the effect of multivitamin use on total mortality (among other outcomes) in the Physicians' Health Study II RCT. Furthermore, the study by Harmon et al. (22) was also excluded as the subsequent study by Shvetsov et al. (23) used the same study population and was more informative. Similarly, the study by Liese et al. (24) was excluded because the HR of the MedDiet with all-cause mortality were only graphically displayed and it was not possible to derive the actual valuesnonetheless, the cohorts analysed in the indicated publication were the same as in three other studies (23, 25, 26) that reported the respective HR and were included in our meta-analysis.
A total of sixteen articles were finally identified through the above process. One further study (27) was identified upon examination of the references of these studies; this was an update of the study conducted by Trichopoulou et al. (28) using the European Prospective Investigation into Cancer and Nutrition (EPIC) multi-centre cohort. However, as the study by Trichopoulou et al. (28) contained more information relevant to the current meta-analysis (RR for each of the included cohorts and RR for each of the components of the MedDiet), we decided to keep the earlier study. Nonetheless, the summary RR of the overall meta-analysis remained the same when the most recent study by Lassale et al. (27) was included instead of the Trichopoulou et al. (28) study.
The studies analysed by Sofi et al. (4) were also included in the current meta-analysis, except for the study by Martínez-González et al. (8) , as the most recent publication by Alvarez-Alvarez et al. (29) used the same cohort and was more informative. Therefore, thirty articles were finally included in the meta-analyses of the MedDiet with all-cause mortality: fourteen published before (7, 16, 28, (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) and sixteen published after June 2013 (up to 31 December 2017) (9, 10, 23, 25, 26, 29, (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) . Detailed characteristics of these studies are shown in Table 1 . In eighteen of these publications, RR of all-cause mortality associated with at least one of the components of the MedDiet were reported.
Data extraction
For each study, data were extracted on study design, country, duration of follow-up, enrolment period, number of subjects or person(time)-at-risk, number of deceased, age of the study population, estimates of RR (e.g. HR) and their corresponding 95 % CI, construction rule of adherence to the MedDiet and range of MDS and covariates adjusted for in the analysis. If a study used more than one MedDiet index to measure the adherence to the MedDiet (9, 23, 29, 34, 36, 40) the one more closely resembling the first, original MedDiet index that appeared in the literature (30, 51) was used. From each study, we selected RR estimates adjusted for the largest number of potential confounders.
The MedDiet was assessed in the vast majority of the studies through FFQ (quantitative or semi-quantitative) enquiring usual dietary intakes over a period preceding enrolment (e.g. previous year). Dietary history (32, 36, 37) , dietary records or weighted food records (35, 39, 41, 42) and 24-h dietary recall (43) were also used. Most FFQ had been validated for (at least some) dietary intakes of the MedDiet components.
RR for all-cause mortality were reported: (a) only for continuous increments of MDS (e.g. one or two units) in nine studies (7, 9, 16, (30) (31) (32) 40, 42, 50) , (b) only as a comparison of different categories of MDS in ten studies (23, 25, 26, 29, 34, 39, 41, (47) (48) (49) and (c) for both (a) and (b) in eleven studies (10, 28, 33, (35) (36) (37) (38) (43) (44) (45) (46) . Categories of MDS were defined arbitrarily or were based on percentiles.
Statistical analysis
Mediterranean diet score. To estimate more closely the association of the MedDiet with all-cause mortality, we considered separately studies that reported RR for contrasting categories of upper to lowest MDS (thus assuming a non-linear association) and studies that estimated RR for continuous increments of MDS (thus assuming a log linear shape of the association). For the former studies, RR for the highest v. lowest study-specific categories of MDS were analysed. For the latter studies, RR were re-estimated (if needed) to correspond to 1SD increment in MDS, in order to account for differences in the range of MDS values.
For studies that did not report SD for the MDS, we assumed the same SD as those reported in other studies that used the same MDS. In the study by Tong et al. (9) , the respective SD was obtained by personal communication with the authors. For the study of Prinelli et al. (44) , the SD of the MDS was obtained by the study of Georgousopoulou et al. (52) , which used the same score and reported its SD. study that were used in the current analysis are shown in this column, labelled for simplicity as MDS. The labels of these indices may be different in the original publications.
† Associations of (at least one) MedDiet components with mortality were reported in this study.
Mediterranean diet components. Intakes of the following nine major MedDiet components were examined: vegetables, legumes, fruit/nuts, cereals, fish and shellfish, meat and meat products, milk and dairy products, alcohol and lipid ratio in any way this was defined (e.g. monounsaturated-to-saturated, mono + polyunsaturated-to-saturated and so on). We also considered RR reported for olive oil or wine intakes as these are the main sources of MUFA and alcohol intake, respectively, in the typical MedDiet.
Similarly to the analysis of MDS, mortality RR for each of the indicated food groups/nutrients were estimated in some studies for continuous increments in the intake of the MDS component or as comparisons of categories of the component intake. For continuous increments, we re-estimated mortality RR for one study-specific SD increment in order to account for differences in the intakes of the MedDiet components across different populations. Among studies reporting mortality RR for different categories of MedDiet components, the vast majority contrasted the above/below-median study-specific consumptions. For studies that used other categories of comparison, we considered in our meta-analysis the comparison that resembled more the above/below-median comparison.
Meta-analysis of Mediterranean diet score and Mediterranean diet score components. Summary RR were estimated by combining the study-specific RR (considered as explained above) using random-effects models to take into account the between-study heterogeneity (53) . Each study's ln (RR) was weighted by the inverse of its variance plus the between-study variance component τ 2 computed by the moment estimator (53) . Heterogeneity among studies was evaluated with χ 2 test and I 2 statistic (54, 55) . Publication bias was evaluated through funnel plots (56) and with the Egger's test (57) .
We also conducted meta-analyses in strata of geographical area (USA, Australia, Europe (Northern, Central/Eastern, Western, Mediterranean)), range of MDS scale (0-9, >9), in order to account for the different spread of the distribution of the MedDiet indices used in each study, and year of publication (<2010, 2010-2014, >2014). RR estimated from the multi-centre EPIC study (28) were considered both overall and cohort-specific in meta-analyses stratified by country.
Sensitivity analyses were also conducted by omitting one study at a time from the analyses and assessing its effect on the overall summary RR.
The significance threshold was set at 0·05, whereas all statistical analyses were conducted using R statistical software version 3.4.2.
Results
In Table 1 the main characteristics of the thirty articles (including a total of 225 600 deaths) considering a quantitative relation between MDS and all-cause mortality are shown. Out of these, seven were conducted in North America, twenty-two in Europe and one in Australia. Most studies used a 9-or 10-scale MedDiet index, except for the studies conducted by Buckland et al. (37) , Prinelli et al. (44) , Limongi et al. (47) , Stefler et al. (10) and
Whalen et al. (48) , which used indices of broader ranges. Studies by Mitrou et al. (34) , Tognon et al. (36) , Tognon et al. (40) , Shvetsov et al. (23) , Tong et al. (9) and Alvarez-Alvarez et al. (29) used more than one MedDiet index; from these the traditional MDS, the refined version of the modified Mediterranean diet score (refined mMDS), the alternate MDS without energy adjustment in each of the MedDiet components, the MDS based on cohortspecific medians (mMDS) and the MDS proposed by Trichopoulou et al. (51) , respectively, were considered in the current meta-analyses, all labelled as MDS for reasons of simplicity.
Highest v. lowest level of adherence to the Mediterranean diet in relation to all-cause mortality Fig. 2 shows the RR of all-cause mortality for the study-specific highest v. lowest MDS levels of adherence among the twentyone studies, which reported such associations. In most studies that used an MDS ranging from 0 to 8/9, the highest/lowest level of adherence was 6-8 or 6-9 v. 0-2 or 0-3, respectively, except for the studies by Tognon et al. (36) (6-9 v. 0-5), van den Brandt (38) All studies reported inverse associations, which were statistically significant in sixteen of them. Only one study (41) reported an increased (non significant) mortality risk (RR: 1·15, 95 % CI, 0·81, 1·64) with increased MDS.
The summary mortality ratio for the highest v. lowest MDS level indicates an inverse and significant association: RR 0·79 (95 % CI 0·77, 0·81). Heterogeneity was moderate overall (I 2 = 42 %; P-heterogeneity 0·02).
All-cause mortality in relation to 1SD increase in adherence to the Mediterranean diet
In Fig. 3 , RR of all-cause mortality per one study-specific SD increase in MDS are shown for the twenty studies with available information. Study-specific SD ranged from 1·4 (28) to 5 (44) units in MDS. Inverse associations, statistically significant in fifteen studies, were reported in all publications, except for the study by Lasheras et al. (31) , which reported increased albeit not significant mortality among eighty-seven Spanish people ≥80 years of age for a 1·7-unit increase in MDS.
The summary mortality RR per 1 SD MDS increment was 0·92 (95 % CI 0·90, 0·94), with moderate-to-high heterogeneity (I 2 = 56 %; P-heterogeneity <0·01).
Subgroup analysis
Summary RR (95 % CI) for the highest v. lowest MDS level of adherence, as well as per 1SD MDS increment in strata of selected covariates, are shown in Table 2 . As only two of the studies reporting RR for continuous increments of MDS were conducted outside Europe (one in USA and one in Australia), stratified meta-analysis of RR per 1SD increment in MDS by geographical location was undertaken only among European studies.
RR of highest v. lowest MDS among studies undertaken in USA and Europe were 0·78 (95 % CI 0·76, 0·80) and 0·82 (95 % CI 0·78, 0·88), respectively, with higher heterogeneity observed among the US (I 2 = 55 %, P-heterogeneity 0·02) rather than European studies (I 2 = 10 %, P-heterogeneity 0·33). In analysis confined to European studies, stratification by geographical location revealed stronger summary RR among Mediterranean populations, and weakest ones among the fewer studies conducted in central/eastern Europe for both the highest/lowest or the per SD increment in MDS. Similar summary RR were estimated among studies with different spread of distribution of MDSthat is, those that used MDS scales of 0-9 or greater. Stratification by publication year revealed high consistency in RR after 2011, when the majority of the studies were published ( Fig. 6(a) and (b) ).
Heterogeneity was evident by country location. Across European studies heterogeneity was evident for RR corresponding to 1SD increment in MDS, but not for studies contrasting highest/lowest level of adherence to the MedDiet.
Sensitivity analysis and publication bias. In sensitivity analysis, the summary mortality RR in association with MDS adherence (highest v. lowest or per SD increment) did not change appreciably when each study was excluded in turn, and the RR was estimated from the remaining studies (mortality RR of highest v. lowest MDS ranged from 0·78 to 0·79; mortality RR per SD increment ranged from 0·92 to 0·93). The funnel plots of individual RR for the highest v. lowest MDS, and for the per SD MDS increment are shown in Figs. 4 and 5, respectively. There was no indication of publication bias for studies reporting RR for the highest v. lowest MDS adherence (P-value 0·67), but there was evidence for publication bias for studies reporting RR for 1SD increment in MDS (P < 0·01), probably owing to the absence of studies reporting less precise RR showing increased mortality with continuous increments of MedDiet adherence. Nevertheless, when we used the trim-and-fill method including the missing studies, the estimated association between the per-MDS increment and mortality did not change appreciably and retained its statistical significance.
All-cause mortality in relation to intakes of components of the Mediterranean diet. In all, eighteen studies reported associations of at least one component of the MedDiet with allcause mortality (7, 10, 16, (28) (29) (30) (31) (32) (33) (36) (37) (38) 40, (42) (43) (44) 47, 50) . The studies by Knoops et al. (32) and Lagiou et al. (33) reported RR only for alcohol intake; however, the latter study reported mortality RR contrasting high v. moderate ethanol consumption, which was incompatible with the contrasting categories of alcohol intake reported in the rest of the studies (mostly above/below median or moderate v. other). Therefore, that article was not included in the meta-analysis of alcohol intake. Moreover, the study by Vormund et al. (43) reported mortality ratios contrasting consumers v. non-consumers for each of the MedDiet components; these categories of comparison were incompatible with those used in the rest of the studies (above/below median or per specific MDS increment). Thus, the indicated publication was also not included in the meta-analysis of MedDiet components in relation to mortality.
In Table 3 , the summary RR of mortality (from random effects models) corresponding to the above/below median intake comparison, as well as to moderate intake v. other for alcohol consumption, are shown for each of the nine components of the MDS. Results from the meta-analyses of mortality RR per SD increment were in the same direction. Summary RR were based on different number of studies for each component, as some studies reported associations for a few components only. Table 3 reveals those MedDiet components that showed a significant association with all-cause mortality either inverse -(a) fruit/nuts, (b) vegetables, (c) alcohol (moderate v. other)or positivemeat. With respect to the rest of the components, null associations were estimated for legumes and fish intake, weak/ minimal inverse associations for cereal and lipid ratio intakes, respectively, and a weak positive association for dairy intakes.
Olive oil in relation to mortality was investigated in four studies (10, 37, 44, 47) , with RR reflecting the above v. below median intake comparison in all of them except for the study by Buckland et al. (37) who reported RR for the highest (>24·7 g/d) v. lowest (<13·7 g/d) consumption. No detailed information of the type of olive oil was given in these four studies. The summary RR of these studies was 0·97 (95 % CI 0·82, 1·15). Similarly, RR for wine intake in association with all-cause mortality were reported in two studies (40, 42) comparing the above/below median intakes. The summary RR based on these two studies was 0·87 (95 % CI 0·78, 0·97).
In Fig. 7 , the excess relative risk (ERR) associated with each of the MedDiet components is depicted as estimated from the summary RR. The ERR was highest for moderate alcohol intake (−14 %), followed by above-the-median intakes: fruit (−12 %), meat (7 %) and vegetable (−6 %) intakes, cereals (−5 %), dairy (5 %) and lipid ratio (−2 %) intakes. The ERR for fish and legume intake were close to zero.
Discussion
In the present meta-analyses of all published prospective investigations up to 31 December 2017, including thirty studies and 225 600 deaths, we found an inverse, significant association between conformity to the MedDiet and all-cause mortality. We also estimated summary mortality ratios for each of the nine components of the MedDiet. In these analyses, relatively stronger and statistically significant associations were highlighted for moderate alcohol (RR = 0·86) consumption, as well as for above-the-median intakes of fruit (RR = 0·88), meat (RR = 1·07) and vegetables (RR = 0·94).
Our findings are in agreement with recently published studies (4, 6) . In the last meta-analysis of observational studies published up to June 2013, Sofi et al. (4) 0·91 (95 % CI 0·89, 0·93) associated with a 2-point increment in MDS with moderate heterogeneity. Although previous studies have estimated RR for either continuous increments or categorical comparisons of MDS, we have chosen to provide RR separately for the two approaches, avoiding making any assumptions for transforming the reported RR (i.e. from expressing continuous increments to reflecting categorical comparisons of MDS and vice versa). Our approach adds to interpreting and communicating the results regarding the health benefits associated with the MedDiet: realistic increments of the adherence to the MedDiet result in a reduction of 8 % in allcause mortality, whereas this survival benefit achieves its maximum (21 % reduction in mortality rates) among adherers at the highest as compared with those in the lowest percentiles of MDS.
In our meta-analysis, we observed moderate heterogeneity across studies, similarly to previous meta-analyses (4) . When exploring this heterogeneity in strata of pre-defined covariates, none of the stratification variables had any appreciable influence on the summary RR, which were always indicative of inverse and significant associations of the MedDiet with mortality. Heterogeneity, however, was decreased, in a significant manner, among European as compared with US studies. Studies across USA and Europe may differ in definitions and components of MDS, intakes of foods included in MDS, correlations between components of MDS and so on. No appreciable heterogeneity across European studies was observed in our investigation, similarly to previous meta-analyses (58) , even though the reported associations were somewhat stronger in Mediterranean rather than in western and northern European countries. This is expected, as Mediterranean populations are likely to have greater adherence to MedDiet scores. The constructing algorithm underlying MedDiet indices, which usually results in different MDS ranges of scales, did not seem to influence the results of our meta-analysis. Studies published before 2011 were fewer and smaller with more imprecise RR as compared with the large body of studies published after 2011. Nevertheless, heterogeneity by year of publication (before/after 2011) was not statistically significant.
The beneficial effect of the MedDiet on several health outcomes has been often attributed to constituents such as vitamins, minerals, fibre and antioxidants abundant in foods of plant origin, ethanol and polyphenols in wine (the most frequent type of alcoholic beverage consumed in the traditional MedDiet) and antioxidative and anti-oncogenic effects of oleic acid abundant in olive oil, highly consumed in the Med-Diet (59) (60) (61) . In our study, we attempted to evaluate the contribution of each component on the association with mortality of the MedDiet in toto, by performing suitable meta-analyses. Examination of the summary mortality ratios revealed inverse or null associations for higher intakes of all MedDiet components except for meat and dairy intakes, for which the associations were positive, as reflected in the scores. Moreover, our results indicated highest protection for moderate (v. excessive or minimal) alcohol consumption (14 %), followed by above (v. below)-the-median consumption of fruit (12 %). Low (belowthe-median) consumption of meat and dairy products and high (above-the-median) consumption of vegetables and cereals were associated with lower mortality rates of about 5-6 %. The association with mortality of the lipid ratio was minimal (2 %), whereas consumption of fish and seafood, as well as of legumes, was not associated with mortality. The importance of alcohol in the association of MDS with mortality may be partly owing to the more valid, as compared with the rest of the MedDiet components, reporting of habitual intake of alcoholic beverages. On the other hand, fruit and vegetables, as well as meat and meat products, are foods widely consumed in the countries included in this meta-analysis and therefore a 'true' association with mortality may be more easily detected as compared with other non-frequently consumed foods in the non-Mediterranean countries, such as legumes and olive oil (included in the lipid ratio). A few studies have investigated the contribution of the MedDiet components in the association of this diet with mortality. An empirical investigation by Trichopoulou et al. (7) (included in the current meta-analysis) based on the Greek EPIC also highlighted the high importance of moderate (v. excessive or minimal) alcohol intake and the neutral contribution of fish intake to the association of the MedDiet with mortality. Although the magnitudes of the RR in that study were, naturally, different from our summary RR, the order of the relative importance of the different components was quite similar in their study and ours.
Our results regarding the contribution of the individual components to the overall association of the MedDiet with mortality should be interpreted with caution as (1) intakes of the indicated foods/nutrients have been collected with different methods and differ (on average) across studies included in the meta-analysis, (2) different number of studies are used in the meta-analysis of each of the individual components and (3) definitions of the foods comprising the MedDiet components are different across studies (e.g. only whole-grain cereals are used in the alternate MDS, but all types of cereals are included in the original MDS). Nevertheless, the summary RR for the nine MedDiet components are generally in agreement with the current literature. Several studies have reported the survival benefit of moderate alcohol intake (62) , of higher intakes of vegetables, fruit and nuts (63, 64) and of low/no intake of meat (especially red meat) and meat products (65, 66) . For dairy products, a recent meta-analysis (5) did not find an association with mortality. For cereals, results are controversial, as they include whole-grain cereals that have been found to be inversely associated with mortality (5, 67) , as well as refined grains for which no or a moderate direct association was found in previous metaanalyses (5, 68) . Fish and legume intakes have been inversely associated with mortality (5, 69, 70) . In our study, we did not detect an association with mortality for these two food groups, probably owing to their low intakes evident in the studies included in the component-specific meta-analyses. We did not find an appreciable influence in mortality of the lipid ratio intake, either. Although this ratio was proposed originally to reflect a high monounsaturated (mainly owing to high consumption of olive oil in the MedDiet) as opposed to saturated lipid intake, this is not always the case: in many studies undertaken in countries that culturally do not consume olive oil, monounsaturated lipid intake can be of animal origin, whereas polyunsaturated lipid intakes are usually added in the nominator in order to reflect lipid intake from plant origin. In a metaanalysis of Schwingshackl & Hoffmann (71) examining the role of MUFA (from plant and animal origin) and olive oil on mortality, the most consistent findings for reduced mortality were for olive oil intake. Major strengths of our study are the thorough systematic review, allowing us to estimate the association of the MedDiet with all-cause mortality by comparing the extremes of adherence with this diet, as well as for smaller, more easily achievable changes in habitual intakes for those who wish to follow this diet. To our knowledge, this is the first study evaluating the relative merit of the individual components in the overall association of the MedDiet with mortality (5) . In all, two other meta-analyses have also looked at the individual components of the MedDiet in relation to incidence of, and mortality from, CVD (72) and cancer (5) . It is difficult to compare the results of these investigations with ours owing to differences in the studies included, the end points used and the different contrasting categories used for each component. Nevertheless, the aforementioned investigations also found inverse associations for the incidence of/mortality from CVD and cancer with respect to higher intake of vegetables and fruit, and a positive association with respect to higher meat intake (albeit not statistically significant). Schwingshackl et al. (5) also found moderate ethanol consumption being associated with a reduction in cancer incidence/mortality. On the other hand, Grosso et al. (72) found a neutral effect of alcohol on cardiovascular incidence/mortality (0·97, 95 % CI 0·88 1·07) but they have combined RR, which refer both to high v. low and moderate v. other consumptions of alcohol, and therefore their results are not directly comparable to ours.
However, some limitations should also be acknowledged. The studies included in our meta-analysis may have various sources of bias. Misclassification of consumption of the MedDiet components owing to self-reported assessment is likely in the original studies, but this would be non-differential among cohort studies where information is collected long time before mortality.
Another limitation is that adherence to the MedDiet has been evaluated only at recruitment, and individual diet may change over time especially in prospective studies with long follow-up. Nevertheless, a recent study, with a substantial sample size, that used a superior design with repeated measurements of diet and examined changes in adherence to the MedDiet during a very long follow-up also showed a benefit in mortality (15) .
Heterogeneity among RR associated with MDS was not negligible; however, the consistency of our findings with those reported in other meta-analyses of the MedDiet in relation to various health outcomes (6) reassures the accuracy of our results. With respect to confounding, the well-accepted risk factors for mortality were controlled for in many studies, especially the most recent ones, and we used multivariate RR adjusted for all available covariates in our meta-analyses. Finally, the estimated RR referring to the individual components of the MedDiet were based on country-specific medians, which differ across countries, although the use of random-effects models may overcome this problem up to a certain point.
In conclusion, in our systematic meta-analyses of cohort studies, we confirmed the inverse association of the MedDiet with mortality among adults and we provided evidence regarding the contribution of the components of this diet in the overall association. Although the survival benefits of the Med-Diet in toto are important from a holistic and public health point of view, understanding which components most influence the protective role of this diet seems also important in order to better promote the MedDiet as a healthy dietary pattern, as well as to propose changes in the intakes of the components of this diet that can most effectively lower mortality.
